See all eligibility criteria
See protocol details
The purpose of this study is to determine the proportion of patients with a serological prostate specific antigen (PSA) by day 85. A serological PSA response is defined as a reduction from baseline PSA serum concentration of at least 50%, which is confirmed by a second PSA value 28 or more days later.
Show More Criteria
Show More Criteria